# Randomized Cross Over Study to Assess Efficacy and Safety of BDP/FF and Glycopyrrolate

> **NCT01476813** · PHASE2 · COMPLETED · sponsor: **Chiesi Farmaceutici S.p.A.** · enrollment: 281 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** Glycopyrrolate
- **DRUG:** Glycopyrrolate
- **DRUG:** Glycopyrrolate
- **DRUG:** Comparator

## Key facts

- **NCT ID:** NCT01476813
- **Lead sponsor:** Chiesi Farmaceutici S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2012-09
- **Final completion:** 2013-07
- **Target enrollment:** 281 (ACTUAL)
- **Last updated:** 2021-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01476813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01476813, "Randomized Cross Over Study to Assess Efficacy and Safety of BDP/FF and Glycopyrrolate". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01476813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*